Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Chau NG, Perez-Ordonez B, Zhang K, Pham NA, Ho J, Zhang T, Ludkovski O, Wang L, Chen EX, Tsao MS, Kamel-Reid S, Siu LL.

Head Neck Oncol. 2011 Feb 27;3:11. doi: 10.1186/1758-3284-3-11.

2.

Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.

Young RJ, Rischin D, Fisher R, McArthur GA, Fox SB, Peters LJ, Corry J, Lim A, Waldeck K, Solomon B.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1230-7. doi: 10.1158/1055-9965.EPI-10-1262. Epub 2011 Apr 5.

3.

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.

Licitra L, Mesia R, Rivera F, Remenár E, Hitt R, Erfán J, Rottey S, Kawecki A, Zabolotnyy D, Benasso M, Störkel S, Senger S, Stroh C, Vermorken JB.

Ann Oncol. 2011 May;22(5):1078-87. doi: 10.1093/annonc/mdq588. Epub 2010 Nov 3.

4.

Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.

Nakano T, Yamamoto H, Nakashima T, Nishijima T, Satoh M, Hatanaka Y, Shiratsuchi H, Yasumatsu R, Toh S, Komune S, Oda Y.

Hum Pathol. 2016 Apr;50:51-61. doi: 10.1016/j.humpath.2015.11.001. Epub 2015 Nov 17.

PMID:
26997438
5.

Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib.

Agulnik M, da Cunha Santos G, Hedley D, Nicklee T, Dos Reis PP, Ho J, Pond GR, Chen H, Chen S, Shyr Y, Winquist E, Soulieres D, Chen EX, Squire JA, Marrano P, Kamel-Reid S, Dancey J, Siu LL, Tsao MS.

J Clin Oncol. 2007 Jun 1;25(16):2184-90.

6.

Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.

Uribe P, Gonzalez S.

Pathol Res Pract. 2011 Jun 15;207(6):337-42. doi: 10.1016/j.prp.2011.03.002. Epub 2011 Apr 29. Review.

PMID:
21531084
7.

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.

Vermorken JB, Psyrri A, Mesía R, Peyrade F, Beier F, de Blas B, Celik I, Licitra L.

Ann Oncol. 2014 Apr;25(4):801-7. doi: 10.1093/annonc/mdt574. Epub 2014 Feb 26.

8.

c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.

Baschnagel AM, Williams L, Hanna A, Chen PY, Krauss DJ, Pruetz BL, Akervall J, Wilson GD.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):701-7. doi: 10.1016/j.ijrobp.2013.11.013.

PMID:
24521684
9.

Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer.

Pajares B, Trigo JM, Toledo MD, Álvarez M, González-Hermoso C, Rueda A, Medina JA, de Luque V, Jerez JM, Alba E.

BMC Cancer. 2013 Jan 18;13:26. doi: 10.1186/1471-2407-13-26.

10.

Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.

Fei J, Hong A, Dobbins TA, Jones D, Lee CS, Loo C, Al-Ghamdi M, Harnett GB, Clark J, O'Brien CJ, Rose B.

Ann Surg Oncol. 2009 Oct;16(10):2908-17. doi: 10.1245/s10434-009-0579-1. Epub 2009 Jul 15.

PMID:
19603236
11.

The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.

Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, Koong A, Pourmand N, Le QT.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):553-61. doi: 10.1016/j.ijrobp.2009.02.015.

12.

[Relationship between human papilloma virus infection and expression of p16 and EGFR in head and neck squamous cell carcinoma and their prognostic significance].

Ma L, Wang D, Wufuer A, Wu R, Zhang S, Wang R.

Zhonghua Zhong Liu Za Zhi. 2014 Jan;36(1):23-8. Chinese.

PMID:
24685082
13.

Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.

Hama T, Yuza Y, Saito Y, O-uchi J, Kondo S, Okabe M, Yamada H, Kato T, Moriyama H, Kurihara S, Urashima M.

Oncologist. 2009 Sep;14(9):900-8. doi: 10.1634/theoncologist.2009-0058. Epub 2009 Sep 2. Erratum in: Oncologist. 2009 Oct;14(10):1050.

14.

Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.

Tinhofer I, Klinghammer K, Weichert W, Knödler M, Stenzinger A, Gauler T, Budach V, Keilholz U.

Clin Cancer Res. 2011 Aug 1;17(15):5197-204. doi: 10.1158/1078-0432.CCR-10-3338. Epub 2011 Jun 8.

15.

Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.

Rampias T, Pectasides E, Prasad M, Sasaki C, Gouveris P, Dimou A, Kountourakis P, Perisanidis C, Burtness B, Zaramboukas T, Rimm D, Fountzilas G, Psyrri A.

Ann Oncol. 2013 Aug;24(8):2124-31. doi: 10.1093/annonc/mdt013. Epub 2013 Feb 13.

16.

Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.

Walker F, Abramowitz L, Benabderrahmane D, Duval X, Descatoire V, Hénin D, Lehy T, Aparicio T.

Hum Pathol. 2009 Nov;40(11):1517-27. doi: 10.1016/j.humpath.2009.05.010. Epub 2009 Aug 27.

PMID:
19716155
17.

Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma.

Husain H, Psyrri A, Markovic A, Rampias T, Pectasides E, Wang H, Slebos R, Yarbrough WG, Burtness B, Chung CH.

Laryngoscope. 2012 Dec;122(12):2762-8. doi: 10.1002/lary.23647. Epub 2012 Oct 19.

18.

Molecular biology of squamous cell carcinoma of the head and neck: relevance and therapeutic implications.

Schmitz S, Machiels JP.

Expert Rev Anticancer Ther. 2010 Sep;10(9):1471-84. doi: 10.1586/era.10.115. Review.

PMID:
20836682
19.
20.

Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas.

Smilek P, Neuwirthova J, Jarkovsky J, Dusek L, Rottenberg J, Kostrica R, Srovnal J, Hajduch M, Drabek J, Klozar J.

Neoplasma. 2012;59(5):508-15. doi: 10.4149/neo_2012_065.

PMID:
22668015
Items per page

Supplemental Content

Write to the Help Desk